Literature DB >> 31634534

Painful interactions: Microbial compounds and visceral pain.

I A M van Thiel1, S Botschuijver1, W J de Jonge1, J Seppen2.   

Abstract

Visceral pain, characterized by abdominal discomfort, originates from organs in the abdominal cavity and is a characteristic symptom in patients suffering from irritable bowel syndrome, vulvodynia or interstitial cystitis. Most organs in which visceral pain originates are in contact with the external milieu and continuously exposed to microbes. In order to maintain homeostasis and prevent infections, the immune- and nervous system in these organs cooperate to sense and eliminate (harmful) microbes. Recognition of microbial components or products by receptors expressed on cells from the immune and nervous system can activate immune responses but may also cause pain. We review the microbial compounds and their receptors that could be involved in visceral pain development.
Copyright © 2019 The Author(s). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Irritable bowel syndrome; Microbiome; Nociception; Pain

Mesh:

Year:  2019        PMID: 31634534     DOI: 10.1016/j.bbadis.2019.165534

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  10 in total

1.  Nalbuphine alleviates inflammation by down-regulating NF-κB in an acute inflammatory visceral pain rat model.

Authors:  Dijiao Ruan; Yuanyuan Wang; Sisi Li; Chao Zhang; Wenwen Zheng; Cong Yu
Journal:  BMC Pharmacol Toxicol       Date:  2022-06-01       Impact factor: 2.605

2.  Functional Gastrointestinal Disorders and the Microbiome-What Is the Best Strategy for Moving Microbiome-based Therapies for Functional Gastrointestinal Disorders into the Clinic?

Authors:  Ruben A T Mars; Mary Frith; Purna C Kashyap
Journal:  Gastroenterology       Date:  2020-11-28       Impact factor: 22.682

Review 3.  Mechanisms of microbial-neuronal interactions in pain and nociception.

Authors:  Valentina N Lagomarsino; Aleksandar D Kostic; Isaac M Chiu
Journal:  Neurobiol Pain       Date:  2020-12-11

4.  Evaluation of Gut Microbiota in Patients With Vulvovestibular Syndrome.

Authors:  Laura Coda; Paola Cassis; Stefania Angioletti; Cristina Angeloni; Stefania Piloni; Cristian Testa
Journal:  J Clin Med Res       Date:  2021-02-25

5.  The Vaginal Microbiome: III. The Vaginal Microbiome in Various Urogenital Disorders.

Authors:  Francesco De Seta; Risa Lonnee-Hoffmann; Giuseppina Campisciano; Manola Comar; Hans Verstraelen; Pedro Vieira-Baptista; Gary Ventolini; Ahinoam Lev-Sagie
Journal:  J Low Genit Tract Dis       Date:  2022-01-01       Impact factor: 1.925

Review 6.  Using Microbiome-Based Approaches to Deprogram Chronic Disorders and Extend the Healthspan following Adverse Childhood Experiences.

Authors:  Rodney R Dietert; Janice M Dietert
Journal:  Microorganisms       Date:  2022-01-21

Review 7.  Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome.

Authors:  Yoshiyuki Mishima; Shunji Ishihara
Journal:  Int J Mol Sci       Date:  2020-11-17       Impact factor: 5.923

8.  Study on the Salivary Microbial Alteration of Men With Head and Neck Cancer and Its Relationship With Symptoms in Southwest China.

Authors:  Hao-Jiang Zuo; Mei R Fu; Hui-Ling Zhao; Xin-Wen Du; Zi-Yi Hu; Xun-Ying Zhao; Xiao-Qin Ji; Xian-Qiong Feng; Wuerken Zhumajiang; Ting-Hui Zhou; Ya-Li Tian; Xiao-Fang Pei; Rong Yu; Xiu-Ying Hu
Journal:  Front Cell Infect Microbiol       Date:  2020-11-06       Impact factor: 5.293

Review 9.  Silent hypoxia in COVID-19: a gut microbiota connection.

Authors:  Akshita Baiju Gopal; Soumyadeep Chakraborty; Pratyush Kumar Padhan; Alok Barik; Pragyesh Dixit; Debashish Chakraborty; Indrajit Poirah; Supriya Samal; Arup Sarkar; Asima Bhattacharyya
Journal:  Curr Opin Physiol       Date:  2021-07-06

10.  Vulvodynia associated with vulvovaginal microbiome: Neglected due to the COVID-19 pandemic?

Authors:  S Rozani; K Evangelou; C Tsagkaris
Journal:  Ethics Med Public Health       Date:  2021-12-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.